Harvard Bioscience, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.04 | $0.04 | $0.04 |
| Q2 2024 | 1 | $0.05 | $0.05 | $0.05 |
| Q3 2024 | 1 | $0.01 | $0.02 | $0.02 |
| Q4 2024 | 1 | $0.05 | $0.05 | $0.05 |
| Q1 2025 | 2 | -$0.01 | $0.04 | $0.02 |
| Q2 2025 | 1 | $0.03 | $0.04 | $0.04 |
| Q3 2025 | 1 | $0.02 | $0.02 | $0.02 |
| Q4 2025 | 1 | $0.05 | $0.06 | $0.06 |
Harvard Bioscience, Inc. Earnings Date And Information
Harvard Bioscience, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.07. The company had revenue of 21.97 M for the quarter and had revenue of 112.25 M for the year. Harvard Bioscience, Inc. has generated $0 earnings per share over the last year ($-0.0805 diluted earnings per share) and currently has a price-to-earnings ratio of -6.86. Harvard Bioscience, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Harvard Bioscience, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.11 | $23.70 M | $21.97 M | ||
| 08/08/2024 | Q2 2024 | $0.05 | -$0.07 | -0.12 | $26.40 M | $23.10 M |
| 05/07/2024 | Q1 2024 | $0.02 | -$0.11 | -0.13 | $24.51 M | |
| 03/07/2024 | Q4 2023 | $0.05 | -$0.04 | -0.09 | $28.15 M | |
| 11/07/2023 | Q3 2023 | $0.04 | -$0.03 | -0.07 | $28.02 M | $25.36 M |
| 08/08/2023 | Q2 2023 | $0.05 | -$0.02 | -0.07 | $29.50 M | $28.76 M |
| 04/26/2023 | Q1 2023 | $0.01 | $29.98 M | |||
| 03/09/2023 | Q4 2022 | $0.03 | -$0.04 | -0.07 | $28.43 M | |
| 11/08/2022 | Q3 2022 | -$0.08 | $28.87 M | $26.92 M | ||
| 08/04/2022 | Q2 2022 | $0.06 | $30.49 M | $29.21 M | ||
| 05/04/2022 | Q1 2022 | $0.05 | -$0.17 | -0.22 | $28.78 M | |
| 03/11/2022 | Q4 2021 | $0.02 | $33.06 M | |||
| 11/05/2021 | Q3 2021 | -$0.00 | $27.91 M | $29.66 M | ||
| 08/06/2021 | Q2 2021 | -$0.01 | $27.67 M | $29.20 M | ||
| 05/07/2021 | Q1 2021 | -$0.02 | $26.99 M | |||
| 03/12/2021 | Q4 2020 | -$0.02 | $30.98 M | |||
| 11/06/2020 | Q3 2020 | -$0.03 | $24.05 M | $24.04 M | ||
| 08/10/2020 | Q2 2020 | -$0.04 | $22.20 M | $23.31 M | ||
| 05/08/2020 | Q1 2020 | -$0.12 | $23.77 M | |||
| 03/16/2020 | Q4 2019 | -$0.12 | $116.18 M |
Harvard Bioscience, Inc. Earnings: Frequently Asked Questions
-
When is Harvard Bioscience, Inc.'s earnings date?
Harvard Bioscience, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
-
How can I listen to Harvard Bioscience, Inc.'s earnings conference call?
The conference call for Harvard Bioscience, Inc.'s latest earnings report can be listened to online.
-
How can I read Harvard Bioscience, Inc.'s conference call transcript?
The conference call transcript for Harvard Bioscience, Inc.'s latest earnings report can be read online.
-
How much revenue does Harvard Bioscience, Inc. generate each year?
Harvard Bioscience, Inc. (:HBIO) has a recorded annual revenue of $112.25 M.
-
How much profit does Harvard Bioscience, Inc. generate each year?
Harvard Bioscience, Inc. (:HBIO) has a recorded net income of $112.25 M. Harvard Bioscience, Inc. has generated $-0.0805 earnings per share over the last four quarters.
-
What is Harvard Bioscience, Inc.'s price-to-earnings ratio?
Harvard Bioscience, Inc. (:HBIO) has a price-to-earnings ratio of -6.86 and price/earnings-to-growth ratio is 0.21.
